Lexicon Pharmaceuticals, Inc. Financial Ratios — LXRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-29.15	-27.47	-32.24	-26.91	-0.83	-23.31	-26.97	-33.45	37.08	-18.85	-51.52	-61.56	-83.6	-75.93	-20.83
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	97.93	96.06	99	91.96	100	100	92.94	98.02	99.45
EBITDA Margin (%)	-5,804.71	-9,047.57	-4,706.62	-375.58	8.45	-161.34	-140.17	-163.39	52.81	-745.09	-29,224.83	-72,489.21	-14,264.95	-634.2	-98.21
Operating Margin (%)	-5,804.71	-9,047.57	-4,706.62	-375.58	8.45	-161.34	-140.17	-163.39	52.81	-745.09	-29,224.83	-72,489.21	-14,264.95	-634.2	-98.21
Incremental Operating Margin (%)	- -	- -	- -	- -	90.36	- -	- -	- -	105.6	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-6,285.29	-10,120.39	-4,686.14	-439.15	-3.6	-165.85	-147.95	-190.71	38.54	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Profit Margin (%)	-6,285.29	-10,120.39	-4,686.14	-438.85	-3.6	-165.85	-134.14	-190.71	40.4	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Net Income to Common Margin (%)	-6,285.29	-10,120.39	-4,686.14	-438.85	-3.6	-165.85	-134.14	-190.71	40.4	-244.11	-29,448.99	-73,341.01	-14,710.88	-644.78	-101.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	25	23	22	108	103	101	246	245	246	13	2	55	106	108	63
ST Debt	1	2	2	20	2	16	14	1	12	12	1	1	1	1	6
LT Debt	23	22	20	88	101	85	232	244	234	1	1	54	105	107	57
Total Debt/EBITDA	-0.23	-0.24	-0.21	-1.25	9.36	-0.79	-1.91	-2.37	1.44	-0.07	-0.03	-0.55	-0.62	-0.55	-1.28
Net Debt/EBITDA	1.5	0.07	0.15	0.34	-9.1	-0.43	-1.43	-1.59	1.23	0.64	0.74	-0.02	-0.45	-0.17	-0.4
Total Debt/EBIT	-0.23	-0.24	-0.21	-1.25	9.36	-0.79	-1.91	-2.37	1.44	-0.07	-0.03	-0.55	-0.62	-0.55	-1.28
Net Debt/EBIT	1.5	0.07	0.15	0.34	-9.1	-0.43	-1.43	-1.59	1.23	0.64	0.74	-0.02	-0.45	-0.17	-0.4
EBITDA to Interest Expense	-42.46	-46.61	-53.06	-38.1	1.64	-19.47	-18.4	-4.97	8.23	-12.29	-108.59	-36.24	-13.11	-12.65	-5.87
EBITDA-CapEx/Interest Expense	-42.93	-46.84	-53.93	-38.13	1.5	-19.51	-18.44	-4.98	8.22	-12.3	-110.11	-36.72	-13.15	-12.72	-5.87
EBIT to Interest Expense	-42.46	-46.61	-53.06	-38.1	1.64	-19.47	-18.4	-4.97	8.23	-12.29	-108.59	-36.24	-13.11	-12.65	-5.87
Interest Expense	3	2	2	2	7	7	7	21	21	15	1	3	13	16	8
Common Equity/Total Assets	-183.3	-241.9	-366.01	-234.24	-170.08	-262.87	-312.72	-517.88	-321.11	-686.93	-1,086.58	-818.09	-770	-659.1	-1,090.46
Long-Term Debt/Equity (%)	7.88	8.2	11.85	30.81	35.32	54.11	339.23	- -	199.97	0.39	1.05	46.11	112.53	73.46	52.62
Long-Term Debt/Capital (%)	-3.07	-2.5	-2.05	-8.78	-10.04	-7.41	-20.69	-19.89	-21.37	-0.04	-0.08	-3.52	-6.31	-5.77	-2.9
Long-Term Debt/Total Assets (%)	5.45	5.88	7.36	18.56	15.49	17.91	53.05	85.83	56.06	0.3	0.87	27.79	45.67	35.93	30.59
Total Debt/Equity (%)	8.37	8.79	12.86	37.91	36.01	64.45	359.88	-927.86	209.85	8.19	2.01	47.21	113.91	74.27	58.42
Total Debt/Capital (%)	-3.26	-2.68	-2.23	-10.8	-10.23	-8.83	-21.95	-19.98	-22.43	-0.92	-0.15	-3.6	-6.39	-5.83	-3.21
Total Debt/Total Assets (%)	5.78	6.31	7.98	22.84	15.79	21.33	56.28	86.23	58.83	6.29	1.66	28.46	46.23	36.32	33.96
Net Debt to Equity	-54.24	-2.61	-9.18	-10.42	-35	34.85	269.55	-623.43	178.54	-73.3	-56.4	1.91	82.74	23.05	18.3
Net Debt/Capital (%)	16.98	0.77	1.53	2.61	8.28	-4.59	-15.58	-12.6	-18.47	7.57	4.13	-0.14	-4.58	-1.75	-0.99
EBITDA	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49
EBITDA-CapEx	-109	-99	-106	-86	10	-128	-129	-103	170	-179	-88	-102	-172	-198	-49
Operating Income (Loss)	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	13.17	12.21	6.69	7.55	4.24	2.1	2.95	4.36	4.16	3.25	3.92	5.97	5.39	5.26	4.61
Current Ratio	13.36	12.63	6.97	8.21	4.33	2.17	3.05	4.72	5.17	3.37	4.02	6.08	5.6	5.44	4.88
Quick Ratio	13.19	12.28	6.73	7.57	4.25	2.15	2.99	4.52	5.02	3.26	3.92	5.97	5.42	5.34	4.73
CFO/Avg Current Liab	-5.47	-4.76	-4.85	-2.35	2.2	-1.22	-1.37	-2.09	2.23	-2.55	-2.52	-3.92	-5.92	-4.66	-2.05
Common Equity/Total Assets	-183.3	-241.9	-366.01	-234.24	-170.08	-262.87	-312.72	-517.88	-321.11	-686.93	-1,086.58	-818.09	-770	-659.1	-1,090.46
Long-Term Debt/Equity (%)	7.88	8.2	11.85	30.81	35.32	54.11	339.23	- -	199.97	0.39	1.05	46.11	112.53	73.46	52.62
Long-Term Debt/Capital (%)	-3.07	-2.5	-2.05	-8.78	-10.04	-7.41	-20.69	-19.89	-21.37	-0.04	-0.08	-3.52	-6.31	-5.77	-2.9
Long-Term Debt/Total Assets (%)	5.45	5.88	7.36	18.56	15.49	17.91	53.05	85.83	56.06	0.3	0.87	27.79	45.67	35.93	30.59
Total Debt/Equity (%)	8.37	8.79	12.86	37.91	36.01	64.45	359.88	-927.86	209.85	8.19	2.01	47.21	113.91	74.27	58.42
Total Debt/Capital (%)	-3.26	-2.68	-2.23	-10.8	-10.23	-8.83	-21.95	-19.98	-22.43	-0.92	-0.15	-3.6	-6.39	-5.83	-3.21
Total Debt/Total Assets (%)	5.78	6.31	7.98	22.84	15.79	21.33	56.28	86.23	58.83	6.29	1.66	28.46	46.23	36.32	33.96
CFO/Total Liabilities	-66.15	-89.88	-87.58	-40.36	50.47	-55.19	-50.34	-47.85	37.86	-301.51	-373.24	-115.13	-118.76	-117.26	-87.61
CFO/CapEx	-72.92	-191.99	-52.92	-945.28	203.05	-760.29	-813.13	-1,564.28	1,625.81	-1,643.32	-71.27	-67.01	-344.46	-173.4	- -
Altman's Z-Score	-1.45	1.32	-3.82	-2.24	0.64	-2.22	-4.14	-10.12	-1.01	-10.23	-10.02	-13.68	-14.01	-11.41	-16.98

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	3.38	1.26	2.05	25.05	133.62	18.86	14.89	11.76	10.31	0.84	1.46	6.62	2.32	13.87	17.01
Days Sales Outstanding	107.98	289.59	178.06	14.57	2.73	19.35	24.52	31.04	35.39	432.97	250.48	55.14	157.34	26.32	21.46
Inventory Turnover	- -	- -	- -	- -	- -	- -	1.95	0.75	0.72	0.91	- -	- -	0.45	2.01	1.07
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	187.21	485.59	504.01	401.42	- -	- -	818.03	181.31	341.02
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.08	0.21	0.23	-0.26	- -	- -	0.04	0.03	0.04
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	4,347.31	1,775.52	1,582.67	-1,391.78	- -	- -	9,706.18	11,431.71	10,073.55
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-4,135.59	-1,258.9	-1,043.27	2,226.18	- -	- -	-8,730.81	-11,224.07	-9,711.06
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-162.69	-454.56	-468.62	31.55	- -	- -	-660.69	-154.99	-319.56
Inventories	- -	- -	- -	- -	- -	- -	2	5	4	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	1	4	3	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	440	1,082	924	486	1,379	1,436	1,040	703	441	379	574	317	338	236	418
- Cash & Cash Equivalents	186	30	37	137	203	47	62	80	36	126	64	46	22	67	34
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	25	23	22	108	103	101	246	245	246	13	2	55	106	108	63
Enterprise Value	183	882	816	255	960	1,191	975	788	415	240	489	233	274	107	384
Total Capital	-764	-876	-982	-996	-1,006	-1,149	-1,119	-1,226	-1,096	-1,387	-1,485	-1,534	-1,661	-1,858	-1,954
Total Debt/Capital (%)	-3.26	-2.68	-2.23	-10.8	-10.23	-8.83	-21.95	-19.98	-22.43	-0.92	-0.15	-3.6	-6.39	-5.83	-3.21
Total Debt / EV	0.14	0.03	0.03	0.42	0.11	0.09	0.25	0.31	0.59	0.05	- -	0.24	0.39	1.02	0.16
EV/Sales	98.86	810.37	367.4	11.14	7.39	15.03	10.63	12.46	1.29	9.99	1,642.3	1,679.76	227.88	3.44	7.71
EV/EBITDA	- -	- -	- -	- -	87.37	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	87.37	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	5.02	- -	- -	- -	3.06	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	4.99	- -	- -	- -	3.06	- -	- -	- -	- -	- -	- -
Diluted Market Cap	440	1,082	924	486	1,379	1,436	1,040	703	485	379	574	317	338	236	418
Diluted Enterprise Value	278	1,075	908	457	1,279	1,491	1,224	867	694	266	512	325	422	278	446
EV per Share	3.75	12.61	11.14	3.34	9.27	11.47	9.26	7.44	3.91	2.16	3.36	1.41	1.24	0.33	1.06
TTM Sales	2	1	2	23	130	79	92	63	322	24	- -	- -	1	31	50
TTM EBITDA	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49
TTM Operating Income	-107	-99	-105	-86	11	-128	-129	-103	170	-179	-87	-101	-172	-197	-49
TTM Cash Flow to Firm	-85	-92	-89	-73	191	-169	-179	-128	135	-128	-86	-86	-149	-163	-60
TTM Free Cash Flow to Firm	-84	-92	-87	-73	192	-169	-179	-128	136	-128	-85	-85	-148	-162	-60

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-5.07	-11.52	-10.34	-6.44	7.43	-8.19	-5.62	-4.73	4.25	-2.65	-6.69	-3.62	-2.1	-1.33	-6.15
EV/EBIT	- -	- -	- -	- -	87.37	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
Enterprise Value	183	882	816	255	960	1,191	975	788	415	240	489	233	274	107	384
Low Price	5.67	7.91	11.9	5.6	6.09	7.65	8.07	6.02	1.13	1.03	3.26	1.31	0.92	0.62	0.28
EV/Sales	98.86	810.37	367.4	11.14	7.39	15.03	10.63	12.46	1.29	9.99	1,642.3	1,679.76	227.88	3.44	7.71
EV/EBITDA	- -	- -	- -	- -	87.37	- -	- -	- -	2.44	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	3.39	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-4.38	-8.64	-11.08	-8.02	-207.65	-11.13	-11.86	-8.57	3.87	-4.07	-8.56	-3.9	-2.46	-2.76	-6.88
Price/Earnings High	-6.74	-14.57	-15.67	-10.98	-349.36	-15.5	-15.4	-12.26	6.85	-8.46	-16.02	-6.49	-4.73	-5.96	-11.97
Price/Earnings Low	-2.38	-5.02	-8.38	-4.26	-134.74	-6.04	-6.9	-5.29	0.92	-1.95	-5.41	-2.13	-1.15	-0.99	-2.05
Price/Book Value	-0.56	-1.2	-0.92	-0.44	-1.24	-1.15	-0.76	-0.48	-0.33	-0.27	-0.39	-0.2	-0.19	-0.12	-0.21
Price/Book Value Average	-0.65	-1.06	-1.15	-0.73	-0.88	-1.17	-1.07	-0.7	-0.38	-0.17	-0.5	-0.25	-0.25	-0.28	-0.17
Price/Book Value High	-0.99	-1.79	-1.63	-1	-1.48	-1.63	-1.39	-1	-0.66	-0.35	-0.94	-0.42	-0.47	-0.61	-0.3
Price/Book Value Low	-0.35	-0.62	-0.87	-0.39	-0.57	-0.64	-0.62	-0.43	-0.09	-0.08	-0.32	-0.14	-0.12	-0.1	-0.05
Price/Tangible Book Value	2.2	6.42	12.82	2.61	7.34	24.14	-36.92	-5.8	8.34	3.39	8.31	4.36	6.97	2.33	6.63
Price/Tangible Book Value Average	2.55	5.65	16.01	4.32	5.17	24.58	-51.81	-8.54	9.52	2.13	10.88	5.47	8.96	5.46	5.5
Price/Tangible Book Value High	3.93	9.53	22.64	5.92	8.7	34.25	-67.26	-12.21	16.86	4.43	20.35	9.11	17.26	11.77	9.57
Price/Tangible Book Value Low	1.38	3.28	12.1	2.3	3.36	13.35	-30.16	-5.26	2.27	1.02	6.88	2.99	4.19	1.96	1.63
Price/Sales	237.74	993.8	415.67	21.28	10.6	18.12	11.34	11.12	1.37	15.8	1,925.73	2,277.34	281	7.6	8.38
Price/Sales Average	275.34	874.85	519.33	35.2	7.48	18.45	15.91	16.35	1.56	9.93	2,520.07	2,856.64	361.53	17.81	6.96
Price/Sales High	423.88	1,474.97	734.34	48.17	12.58	25.71	20.66	23.39	2.77	20.65	4,716.58	4,757.37	696.08	38.41	12.1
Price/Sales Low	149.28	508.14	392.57	18.71	4.85	10.03	9.26	10.08	0.37	4.76	1,593.37	1,561.94	168.97	6.39	2.07
Price/Cash Flow	-5	-11.46	-10.14	-6.43	7.46	-8.18	-5.61	-4.73	3.87	-2.65	-6.59	-3.56	-2.09	-1.32	-6.15
Price/Cash Flow Average	-5.79	-10.09	-12.67	-10.64	5.26	-8.33	-7.87	-6.95	4.42	-1.67	-8.63	-4.47	-2.69	-3.1	-5.11
Price/Cash Flow High	-8.91	-17	-17.92	-14.56	8.85	-11.6	-10.22	-9.95	7.83	-3.47	-16.15	-7.44	-5.18	-6.68	-8.88
Price/Cash Flow Low	-3.14	-5.86	-9.58	-5.65	3.41	-4.52	-4.58	-4.29	1.05	-0.8	-5.46	-2.44	-1.26	-1.11	-1.52
Price/Free Cash Flow Average	-5.87	-10.14	-12.91	-10.65	5.24	-8.34	-7.88	-6.96	4.86	-1.67	-8.75	-4.54	-2.7	-3.11	-5.11
Price/Free Cash Flow High	-9.04	-17.09	-18.26	-14.57	8.81	-11.62	-10.23	-9.96	8.6	-3.47	-16.38	-7.56	-5.19	-6.72	-8.88
Price/Free Cash Flow Low	-3.18	-5.89	-9.76	-5.66	3.4	-4.53	-4.59	-4.29	1.16	-0.8	-5.53	-2.48	-1.26	-1.12	-1.52
EV/Sales Average	188.05	868.45	512.3	33.91	6.71	19.14	17.92	18.95	2.21	5.2	2,312.73	2,921.02	430.96	19.15	7.53
EV/Sales High	336.58	1,468.56	727.31	46.88	11.81	26.4	22.67	25.99	3.42	15.92	4,509.25	4,821.75	765.52	39.75	12.67
EV/Sales Low	61.98	501.74	385.54	17.41	4.08	10.72	11.27	12.68	1.02	0.03	1,386.04	1,626.33	238.4	7.73	2.64
EV/EBITDA Average	-3.24	-9.6	-10.88	-9.03	79.34	-11.87	-12.79	-11.6	4.19	-0.7	-7.91	-4.03	-3.02	-3.02	-7.67
EV/EBITDA High	-5.8	-16.23	-15.45	-12.48	139.71	-16.36	-16.17	-15.91	6.47	-2.14	-15.43	-6.65	-5.37	-6.27	-12.9
EV/EBITDA Low	-1.07	-5.55	-8.19	-4.64	48.29	-6.64	-8.04	-7.76	1.94	- -	-4.74	-2.24	-1.67	-1.22	-2.69
EV/EBIT Average	-3.24	-9.6	-10.88	-9.03	79.34	-11.87	-12.79	-11.6	4.19	-0.7	-7.91	-4.03	-3.02	-3.02	-7.67
EV/EBIT High	-5.8	-16.23	-15.45	-12.48	139.71	-16.36	-16.17	-15.91	6.47	-2.14	-15.43	-6.65	-5.37	-6.27	-12.9
EV/EBIT Low	-1.07	-5.55	-8.19	-4.64	48.29	-6.64	-8.04	-7.76	1.94	- -	-4.74	-2.24	-1.67	-1.22	-2.69
Last Price	9.03	15.47	12.6	6.37	13.31	13.83	9.88	6.64	4.15	3.42	3.94	1.91	1.53	0.74	1.15
High Price	16.1	22.96	22.26	14.42	15.79	19.62	18	13.97	8.39	4.47	9.65	3.99	3.79	3.73	1.66
Enterprise Value Average	348	946	1,138	775	872	1,517	1,643	1,198	713	125	689	406	519	595	375
Enterprise Value High	622	1,599	1,616	1,071	1,536	2,093	2,078	1,643	1,101	382	1,344	670	922	1,235	631
Enterprise Value Low	115	546	857	398	531	849	1,033	802	330	1	413	226	287	240	131

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	69	73	73	103	104	104	106	106	106	141	149	189	245	361	363
Diluted Weighted Avg Shares	49	70	73	76	104	104	105	106	117	111	146	166	221	320	363
Basic Weighted Avg Shares	49	70	73	76	104	104	105	106	106	111	146	166	221	320	363
Revenue per Share	0.04	0.02	0.03	0.3	1.26	0.76	0.87	0.6	3.03	0.22	- -	- -	0.01	0.1	0.14
EBITDA per Share	-2.2	-1.41	-1.43	-1.12	0.11	-1.23	-1.22	-0.98	1.6	-1.61	-0.6	-0.61	-0.78	-0.62	-0.13
Operating Income per Share	-2.2	-1.41	-1.43	-1.12	0.11	-1.23	-1.22	-0.98	1.6	-1.61	-0.6	-0.61	-0.78	-0.62	-0.13
Basic EPS, GAAP	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.23	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Basic EPS from Cont Ops	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.23	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Diluted EPS, GAAP	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.11	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Diluted EPS from Cont Ops	-2.39	-1.58	-1.42	-1.31	-0.05	-1.27	-1.17	-1.14	1.11	-0.53	-0.6	-0.62	-0.8	-0.63	-0.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.81	-1.35	-1.24	-0.99	1.78	-1.69	-1.76	-1.4	1.07	-1.29	-0.6	-0.54	-0.73	-0.56	-0.19
Free Cash Flow per Basic Share	-1.83	-1.36	-1.27	-0.99	1.77	-1.69	-1.76	-1.41	1.07	-1.29	-0.61	-0.54	-0.73	-0.56	-0.19
Cash & Equivalents per Share	5.79	3.19	1.76	4.44	5.03	3.34	2.95	1.51	2.56	1.37	0.6	0.83	0.77	0.74	0.27
Book Value per Share	-16.21	-12.86	-13.69	-14.46	-10.7	-12.04	-12.97	-13.9	-12.63	-12.63	-10.21	-9.59	-7.99	-6.15	-5.56
Tangible Book Value per Share	4.1	2.41	0.98	2.44	1.81	0.57	-0.27	-1.14	0.5	1.01	0.47	0.44	0.22	0.32	0.17

Lexicon Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)